Time course analysis in HUVEC treated with VEGF-A showed that upon induction, both MYC and PIM1 were induced with fast kinetics. Immunoprecipitations with anti-MAX antibodies at various time points showed the formation of the MAX/MYC complex from 60 minutes after growth factor stimulation thus corresponding to the appearance of MYC in the nucleus (Fig. 2b, right panel) . Importantly, PIM1 co-immunoprecipitated with MYC and MAX suggesting that a complex containing PIM1 is formed. Endogenous PIM1 was also found to co-immunoprecipitate with endogenous MYC and MAX from 293 cells after serum treatment for 120 minutes (Fig. 2c) , thus demonstrating that a MAX/MYC/PIM1 endogenous complex is also formed in these cells.
As MYC-dependent cell transformation requires MYC boxII (MBII) domain to bind cofactors either in a TRRAP-dependent or -independent manner 24 , we tested whether PIM1 interacts with MYC at MBII via TRRAP. Wild type FLAG-MYC or MYC deleted in the MBII domain (FLAG-MYC MBII) were co-expressed with PIM1 in 293 cells and immunoprecipitated either with FLAG or PIM1 antibodies. Western blot analysis showed reciprocal immunoprecipitation of FLAG-MYC with PIM1, while co-immunoprecipitation was strongly reduced between FLAG-MYC MBII and PIM1 suggesting that MBII domain of MYC is required for the formation of a complex with PIM1 ( Fig. 2d ).
Endogenous TRRAP associated with MYC but not with the FLAG-MYC MBII as previously described 25 . In contrast, PIM1 did not co-immunoprecipitate the endogenous TRRAP (lanes 5 and 10) suggesting that MYC forms independent complexes with PIM1 or TRRAP via the MBII domain.
PIM1 co-localizes with MYC on the chromatin at actively transcribing loci.
To measure PIM1 and MYC association at MYC-target genes, we performed a nuclear distribution analysis of PIM1 with respect to MYC, nascent transcripts, and chromatin markers. Quantitative analysis of double staining with anti-PIM1 and antibodies against different nuclear markers by sequential laser scanning ( H3S10 phosphorylation at the FOSL1 enhancer correlates with PIM1 association.
Next we analysed PIM1 association and H3S10 phosphorylation at FOSL1 (also known as FRA1), a well characterized MYC-target gene 27,28 . FOSL1 contains an upstream functional SRE, which is not sufficient to confer promoter activation, but requires the activity of a downstream enhancer that is activated by MYC and AP-1 27-29 . Upon VEGF-A treatment of HUVEC FOSL1 expression is induced with a peak at 60 minutes (Fig. 4a ).
To demonstrate a direct binding of MYC and PIM1 to the FOSL1 regulatory sequences
ChIP followed by real-time quantitative PCR analysis was performed at various timepoints after VEGF-A treatment. As shown in Figure 4b , we generated primers to analyze four Analysis of the upstream element (probe A) revealed MYC association with this DNA fragment. PIM1 did not associate with this element suggesting that the FOSL1 promoter is bound by an alternative MYC complex. This FOSL1 upstream element showed an increase of H3S10 phosphorylation at 15 minutes after VEGF-A treatment, which was therefore not dependent on PIM1. As the FOSL1 SRE element is constitutively occupied by the ternary complex factor (TCF), which is activated by the RAS/ERK pathway 30 , we further analyzed FOSL1 transcription and H3S10 phosphorylation in the presence of H89, a specific MSK1/MSK2 inhibitor 5 . Cell treatment with H89 affected FOSL1 transcription although a VEGF-A-dependent induction was still observed (Fig. 4d) . The analysis of H3S10ph signal showed specific inhibition of H3S10 phosphorylation at the FOSL1 upstream element but not at the enhancer (Fig. 4e) demonstrating that phosphorylation at the upstream element and at the downstream enhancer are independent from each other and mediated by different kinases. The acetylation pattern at the FOSL1 upstream element showed a significant increase of H3 phosphorylation and acetylation with a peak between 15 and 30 minutes suggesting that, at this site, H3S10 phosphorylation precedes or is concomitant with H3 acetylation at K9 and K14 as previously described for IE promoters 3,4 .
The downstream FOSL1 fragments (analyzed with probes C and D) did not reveal MYC or PIM1 binding, nor the increase of phosphorylated H3S10, while presented elevated levels of acetylated H3. These results demonstrate specific recruitment of PIM1 to the FOSL1 enhancer concomitant with an increase of H3S10 phosphorylation at this site and with transcriptional activation of the gene.
H3S10 phosphorylation at FOSL1 enhancer is mediated by PIM1.
PIM1 depletion using small hairpin RNA (shRNA) was peformed to test whether PIM1 association with the FOSL1 enhancer was required for H3S10 phosporylation. In 293 cells treated with serum MYC, PIM1, and FOSL1 showed a slower kinetics of induction with respect to HUVEC treated with VEGF-A possibly due to the different cell types (cell line versus primary cells). PIM1 silencing strongly inhibited FOSL1 mRNA expression ( Fig. 7b and see Supplementary Information Fig. S3 ). Quantitative ChIP analysis ( showed a faster kinetics of H3S10 phosphorylation that was not affected by PIM1
knockdown. No H3S10 phosphorylation was observed at the downstream fragments (probes C and D). We concluded that H3S10 phosphorylation at the FOSL1 enhancer is PIM1-dependent.
PIM1 and MYC are found to associate at the FOSL1 enhancer with a peak between 90 and 120 minutes. PIM1 silencing significantly reduced PIM1 association at the enhancer without affecting MYC association. The overall pattern of H3 phospho-acetylation at K9
and K14 in 293 cells showed elevated levels of H3 acetylation already present before H3 phosphorylation at the FOSL1 enhancer (probe B) and along the FOSL1 gene (probe C and D) which was not affected by PIM1 silencing.
Moreover, expressing the kinase inactive mutant PIM1-K67M, significantly reduced H3S10ph levels at the FOSL1 enhancer (see Supplementary Information Fig. S3) demonstrating that the kinase activity of PIM1 is required for H3S10 phosphorylation at this site.
PIM1 is recruited by MYC at the FOSL1 and ID2 E box elements.
MYC silencing was performed to analyze whether its expression is required for PIM1 recruitment to the FOSL1 enhancer ( Fig. 6a and see Supplementary Information Fig. S4 ).
We also analyzed MYC-dependent recruitment of PIM1 at the ID2 E box. ID2 is a well Importantly, the reintroduction of wild type FLAG-MYC, but not the FLAG-MYC MBII in MYC-silenced cells restored PIM1 recruitment and H3S10 phosphorylation at both sites ( Fig. 6 f, g, h and see Supplemenrary Information Fig. S4 ). These results establish that MYC, via its MBII domain, recruits PIM1 to the E box elements of these MYC-regulated genes and its recruitment is required for phosphorylating H3S10 at these sites.
PIM1 is required for transcriptional activation of FOSL1 and ID2 genes.
After serum treatment of 293 cells, both FOSL1 and ID2 mRNA were induced with similar kinetics (Fig. 7b, e Table SII, SIII) . Based on this analysis we conclude that PIM1 act as a cofactor for transcriptional regulation in a significant subset of MYC-dependent genes.
PIM1 recruitment to the chromatin by MYC contributes to cell transformation.
Next we investigated the biological relevance of MYC -PIM1 co-operation. To understand whether PIM1 acts as a MYC cofactor in cell transformation we generated chimeric constructs in which PIM1 was directly fused to the N terminal domain of MYC (PIM1-MYC). We found that the PIM1-MYC fusion molecule induced a comparable number of soft agar colonies relative to the co-expression of MYC and PIM1 in the same cells ( Fig. 8b) suggesting that PIM1 recruitment to the chromatin by MYC is required for cooperation between MYC and PIM1 in cell transformation. Since formation of the MYC complex with PIM1 and its recruitment to MYC binding sites requires the MYC MBII domain ( Fig. 2, 6 ), which is essential for MYC oncogenic activity, PIM1 was also fused to the transformation-defective MYC deleted in the MBII domain. Interestingly, we found that the fusion PIM1-MYC MBII, but not co-transfection of MYC MBII with PIM1, was able to rescue, at least in part, the defective MYC-transformation (Fig. 8b) . Importantly, this fusion rescues both transcriptional activity and ability to phosphorylate H3S10 at its recruiting sites (Fig. 8d, f) . In contrast, a chimeric molecule in which PIM1 was fused to a MYC C, a mutant unable to bind to the DNA, was defective for transforming activity and for phosphorylation of H3S10 at the target genes analysed (see Supplementary Information Figure S6 ). Interestingly, the transformed foci induced by the PIM1-MYC fusion grew vigorously in soft agar forming bigger colonies as compared with PIM1KD-MYC (see Supplementary Information Fig. S6 ).
Finally, we tested whether H3 phosphorylation at S10 is required for MYC-dependent Taken together these results show that H3 phosphorylation at MYC-target genes by PIM1
is required for the cooperative effects of PIM1 and MYC in cell transformation.
DISCUSSION
This study defines a new role for the serine/threonine kinase PIM1 as a MYC-dependent modifier of the chromatin. Based on biochemical and functional evidence, we show that following growth factor stimulation a MYC/MAX/PIM1 complex, formed in the nucleus, recruits PIM1 to the chromatin where it phosphorylates H3 at S10. This PIM1-dependent nucleosome phosphorylation is required for the transcriptional activation of a subset of MYC-target genes and MYC-dependent cell transformation.
Immunoprecipitation experiments showed that following growth factor stimulation MYC, in conjunction with MAX, forms a complex with PIM1 in the nucleus. Silencing experiments demonstrated that MYC is required for PIM1 recruitment to the chromatin while PIM1 is necessary to phosphorylate the H3 at S10 on the nuclesosme at E boxes to activate the transcription. According to the current view phosphorylation at the N-terminal domain of H3 could either be required to loosen the interaction between DNA and nucleosome and/or to generate a platform to recruit additional regulatory factors as described in the "histone code" hypothesis 1 . PIM1-dependent phosphorylation at the FOSL1 and ID2 genes is specific for its recruitment sites and does not spread over the genes, suggesting that this phosphorylation is necessary to trigger the enhancer to its active state.
It was previously shown that upon growth factors treatment H3 is phosphorylated at S10
with The recombinant GST-PIM1 construct was obtained by cloning the PIM1 WT and PIM1-K67M cDNA into the bacterial expression vector pGEX-4T and the fused protein was expressed and purified using the standard protocol.
The vector coding for Xenopus leavis histones were expressed and purified as previously 
Selected clones were cultivated in Dulbecco modified essential medium (D-MEM)
containing 10% fetal bovine serum (FBS; Sigma) and 150µg/ml hygromycin for 2/3 weeks.
To perform time course experiments 293 cells were synchronized and then treated with 50% serum shock as described 47 . Primary HUVEC cells were grown in M199 medium supplemented with 15% fetal bovine serum, brain protein extracts and heparin (50 g/ml).
The cells were then starved for 24 hours in M199 medium containing 1% FBS and 0.5%
BSA and induced with 50 ng/ml of VEGF-A.
The cell line P493-6 (kindly provided by Bruno Amati) were grown in RPMI 1640 containing 10% fetal calf serum (FCS) 100 U/ml penicillin, 100µg/ml streptomycin 2mM L-glutammine. MYC repression was obtained with 0.1 µg/ml tetracycline. MYC induction was obtained by washing the cells three times with tetracycline fee phophate buffered saline containing 10% FCS as previously described 27 .
Immunostaining and co-localization analysis. Co-localization experiments were performed on fixed cells as previously described 11 using a Leica TCS SP2 confocal Nucleosome core particles (NCPs) reconstitution was carry out as described 49 .
Chromatin Immunoprecipitation (ChIP) assays were performed as described by Upstate protocols (www.upstate.com). DNA was analyzed by quantitative real-time PCR by using Light Cycler DNA Amplification Kit SYBR Green I (Roche, Mannheim, Germany). All experiment values were normalized to those obtained with a non-immune serum and divided by input, using the procedure previously described 50 . Experiments of MSK1/ MSK2 inhibition were performed by incubating cells with H89 (Calbiochem) as previously described 5 . Oligonucleotide sequences will be provided upon request.
Quantitative RT-PCR analysis was performed as previously described 11 .
Cell transformation and colony formation in soft agarose
The analysis of cell transformation and anchorage independent growth were performed as previously described 36 . Cells transfected with the constructs indicated were suspended at approximately 1x10 4 cells in 2 ml of 0.35% low-melting agarose onto 35-mm culture dish containing 0.7% agarose base. Triplicates were prepared for each tested construct and inspected by eye after crystal violet staining for colony formation after incubation at 37 0 C for 10-14 days. Efficiency of transfection was measured by reporter GFP gene and the levels of proteins were compared by Western blotting.
Antibodies
The antibodies used for in this work are purchased by Santa Cruz Biotechnology (anti- 
